@FiercePharma: J&J faces questions about "phantom recall." Article | Follow @FiercePharma
> Pfizer sold off its swine-vaccine unit in China to Harbin Pharma for $50 million in a sale designed to satisfy the Chinese government's concerns about the Pfizer-Wyeth merger. Report
> Workers at a Teva Pharmaceutical Industries factory in Waterford, Ireland, have voted for industrial action in a row over severance pay. Report
> Americans prefer drugs to talk therapy for depression, with nearly 80 percent taking a pill for the condition, Consumer Reports says. Report
> Shire is deliberating over whether to sue Zydus Pharmaceuticals, which is planning to produce a generic version of Shire's Lialda tablets. Report
> India's Lupin is said to be close to buying a Japanese generics company to beef up its presence in that market. Report
Biotech News
@FierceBiotech: Venter: Synthetic cells will revolutionize vax development. News | Follow @FierceBiotech
@JohnCFierce: I'd be willing to bet $1 that one year from now we'll start seeing the "where-are-all-the-biosimilar-drugs?" stories. Follow @JohnCFierce
> Accentia files reorganization plan. Report
> Focused on Dx, CombiMatrix hunts for new CEO. Story
> Tetraphase hauls in $45M C round to back antibiotic work. News
> J&J's Centocor buys RespiVert. Item
Biotech Research News
> Multaq study raises questions about investigators' objectivity. Item
> Researcher: New vaccine "could eliminate breast cancer." Story
> Are biotech lab workers exposed to hazardous conditions? Report
> Bio-glue holds promise as a wound-healing agent. Article
> Open-source platform spawns cheap insulin. Story
> Experimental chemical nucleozin cripples bird and flu viruses. News
Biotech IT News
> Pilot lets docs tap database to find patient cardiac risk. News
> HealthMap adds more sources for disease tracking. Report
> Cloud computing aids mental illness, ophthalmic projects. Item
> SAS becomes FDA-submission-friendly. Article
> Open source systems lure drug developers. Story
Manufacturing News
> Tylenol champion McNeil saw market in hotheads. News
> Canada finds $1M savings in vax distribution plan clean-up. Story
> Ranbaxy preps for FDA at Indian facility. Report
> Teva to stop making propofol. Item
> Kemwell to double European capacity. Article
And Finally... Male-pattern baldness and an enlarged prostate appear to go hand in hand. Report